·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊÆ÷ÀÎÆ®¸ôTVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ·¹°íÄÍ, ´ÙÄÉ´Ù ÀÚȸ»ç¿¡ 4500¾ï ±Ô¸ð ±â¼úÀÌÀü ±â»çÀÔ·Â : 19.03.22 15:04:03 0 °¡ ÇÃÄ£Ãß°¡ Ç×ü-¾à¹° º¹ÇÕü(ADC) ¿øõ±â¼ú ÀÌÀü¡¦¼±±Þ±Ý ¹× ´Ü±â¸¶ÀϽºÅæ 82¾ï ·¹°íÄ͹ÙÀÌ¿À´Â ÀϺ» Á¦¾à»ç ´ÙÄÉ´ÙÀÇ 100% ÀÚȸ»ç ¹Ð·¹´Ï¾ö(Millenium Pharmaceuticals, Inc.)°ú Ç×ü-¾à¹° º¹ÇÕü(ADC) ¿øõ±â¼ú ÀÌÀü °è¾àÀ» ü°áÇß´Ù°í 22ÀÏ °ø½ÃÇß´Ù. ÃÑ °è¾à±Ý¾×Àº 4548¾ï¿ø(¼±±Þ±Ý ¹× ´Ü±â¸¶ÀϽºÅæ 82¾ï¿ø, ¸¶ÀϽºÅæ 4467¾ï¿ø)ÀÌ¸ç °æ»ó ±â¼ú·á(·Î¿Æ¼)´Â º°µµ´Ù. ¸¶ÀϽºÅæ 4467¾ï¿øÀº ÀÓ»ó´Ü°è, Çã°¡ µî ´Ü°èº° ¼ö·É ¿¹Á¤ÀÌ´Ù. ADC´Â ÀÎü¿¡¼ ÁúȯÀ» À¯¹ßÇÏ´Â Ç׿øÀ» ¼±ÅÃÀûÀ¸·Î °ø°ÝÇÏ´Â Ç×ü¿Í Ä¡·á È¿°ú¸¦ Áö´Ñ ¾à¹°À» °áÇÕÇÏ´Â ±â¼úÀÌ´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · Â÷¼¼´ë ADCÇ÷§Æû ÇÙ½ÉÀº '¸µÄ¿'¡¦È¿´É¡¤µ¶¼º Á¿ì... º¸°ü¼Ò Ç°Áú°ü¸®¾à»ç ¹Ù·Î°¡±â ¼Ûµµ/¿À¼Û/ºÎ»ê Á¦Á¶/Ç°Áú°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â »ó¹Ý±â ¼ö½Ãä¿ë(°³¹ß±âȹÆÀ/ÀÇÇÐÆÀ/RAÆÀ/Àڱݰø½ÃÆÀ/¿µ¾÷Áö¿øÆÀ) ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â ¸ÞÀÌÀú Á¦¾à»ç Á¦Á¶°ü¸®Ã¥ÀÓÀÚ(ÀÎõ ¼Ûµµ. °æ·Â¹«°ü) ¹Ù·Î°¡±â [±¤µ¿Á¦¾à] ÀǾàBDÆÀ °æ·ÂÁ÷¿ø ¸ðÁý ¼·ù ÀüÇü (¾à»ç Àû±Ø ¿ì´ë) ¹Ù·Î°¡±â HK inno.N(ÏÁCJÇコÄɾî) °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â SM(OPH) MSL (À°ÈÞ´ëü 1³â °è¾àÁ÷) ¹Ù·Î°¡±â MSL (Medical Science Liason)_Á¤±ÔÁ÷ ¸ðÁý ¹Ù·Î°¡±â ±¹Á¦¾àÇ°(ÁÖ) °³¹ßºÎ(ÀǾàÇ° Çмú ¾÷¹«) ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â RA/QA ÆÀ¿ø °è¾àÁ÷ ä¿ë ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â MSL / MI / BD / ÀλçÃѹ« / ´ç´¢¸¶ÄÉÆà / Àü½Ã±âȹ / ¾à»ç ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ·¹°íÄÍ, ´ÙÄÉ´Ù ÀÚȸ»ç¿¡ 4500¾ï ±Ô¸ð ±â¼úÀÌÀü URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ·¹°íÄÍ, ´ÙÄÉ´Ù ÀÚȸ»ç¿¡ 4500¾ï ±Ô¸ð ±â¼úÀÌÀü ±â»çÀÔ·Â : 19.03.22 15:04:03 0 °¡ ÇÃÄ£Ãß°¡ Ç×ü-¾à¹° º¹ÇÕü(ADC) ¿øõ±â¼ú ÀÌÀü¡¦¼±±Þ±Ý ¹× ´Ü±â¸¶ÀϽºÅæ 82¾ï ·¹°íÄ͹ÙÀÌ¿À´Â ÀϺ» Á¦¾à»ç ´ÙÄÉ´ÙÀÇ 100% ÀÚȸ»ç ¹Ð·¹´Ï¾ö(Millenium Pharmaceuticals, Inc.)°ú Ç×ü-¾à¹° º¹ÇÕü(ADC) ¿øõ±â¼ú ÀÌÀü °è¾àÀ» ü°áÇß´Ù°í 22ÀÏ °ø½ÃÇß´Ù. ÃÑ °è¾à±Ý¾×Àº 4548¾ï¿ø(¼±±Þ±Ý ¹× ´Ü±â¸¶ÀϽºÅæ 82¾ï¿ø, ¸¶ÀϽºÅæ 4467¾ï¿ø)ÀÌ¸ç °æ»ó ±â¼ú·á(·Î¿Æ¼)´Â º°µµ´Ù. ¸¶ÀϽºÅæ 4467¾ï¿øÀº ÀÓ»ó´Ü°è, Çã°¡ µî ´Ü°èº° ¼ö·É ¿¹Á¤ÀÌ´Ù. ADC´Â ÀÎü¿¡¼ ÁúȯÀ» À¯¹ßÇÏ´Â Ç׿øÀ» ¼±ÅÃÀûÀ¸·Î °ø°ÝÇÏ´Â Ç×ü¿Í Ä¡·á È¿°ú¸¦ Áö´Ñ ¾à¹°À» °áÇÕÇÏ´Â ±â¼úÀÌ´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · Â÷¼¼´ë ADCÇ÷§Æû ÇÙ½ÉÀº '¸µÄ¿'¡¦È¿´É¡¤µ¶¼º Á¿ì... º¸°ü¼Ò Ç°Áú°ü¸®¾à»ç ¹Ù·Î°¡±â ¼Ûµµ/¿À¼Û/ºÎ»ê Á¦Á¶/Ç°Áú°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â »ó¹Ý±â ¼ö½Ãä¿ë(°³¹ß±âȹÆÀ/ÀÇÇÐÆÀ/RAÆÀ/Àڱݰø½ÃÆÀ/¿µ¾÷Áö¿øÆÀ) ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â ¸ÞÀÌÀú Á¦¾à»ç Á¦Á¶°ü¸®Ã¥ÀÓÀÚ(ÀÎõ ¼Ûµµ. °æ·Â¹«°ü) ¹Ù·Î°¡±â [±¤µ¿Á¦¾à] ÀǾàBDÆÀ °æ·ÂÁ÷¿ø ¸ðÁý ¼·ù ÀüÇü (¾à»ç Àû±Ø ¿ì´ë) ¹Ù·Î°¡±â HK inno.N(ÏÁCJÇコÄɾî) °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â SM(OPH) MSL (À°ÈÞ´ëü 1³â °è¾àÁ÷) ¹Ù·Î°¡±â MSL (Medical Science Liason)_Á¤±ÔÁ÷ ¸ðÁý ¹Ù·Î°¡±â ±¹Á¦¾àÇ°(ÁÖ) °³¹ßºÎ(ÀǾàÇ° Çмú ¾÷¹«) ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â RA/QA ÆÀ¿ø °è¾àÁ÷ ä¿ë ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â MSL / MI / BD / ÀλçÃѹ« / ´ç´¢¸¶ÄÉÆà / Àü½Ã±âȹ / ¾à»ç ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ·¹°íÄÍ, ´ÙÄÉ´Ù ÀÚȸ»ç¿¡ 4500¾ï ±Ô¸ð ±â¼úÀÌÀü URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ·¹°íÄÍ, ´ÙÄÉ´Ù ÀÚȸ»ç¿¡ 4500¾ï ±Ô¸ð ±â¼úÀÌÀü ±â»çÀÔ·Â : 19.03.22 15:04:03 0 °¡ ÇÃÄ£Ãß°¡ Ç×ü-¾à¹° º¹ÇÕü(ADC) ¿øõ±â¼ú ÀÌÀü¡¦¼±±Þ±Ý ¹× ´Ü±â¸¶ÀϽºÅæ 82¾ï ·¹°íÄ͹ÙÀÌ¿À´Â ÀϺ» Á¦¾à»ç ´ÙÄÉ´ÙÀÇ 100% ÀÚȸ»ç ¹Ð·¹´Ï¾ö(Millenium Pharmaceuticals, Inc.)°ú Ç×ü-¾à¹° º¹ÇÕü(ADC) ¿øõ±â¼ú ÀÌÀü °è¾àÀ» ü°áÇß´Ù°í 22ÀÏ °ø½ÃÇß´Ù. ÃÑ °è¾à±Ý¾×Àº 4548¾ï¿ø(¼±±Þ±Ý ¹× ´Ü±â¸¶ÀϽºÅæ 82¾ï¿ø, ¸¶ÀϽºÅæ 4467¾ï¿ø)ÀÌ¸ç °æ»ó ±â¼ú·á(·Î¿Æ¼)´Â º°µµ´Ù. ¸¶ÀϽºÅæ 4467¾ï¿øÀº ÀÓ»ó´Ü°è, Çã°¡ µî ´Ü°èº° ¼ö·É ¿¹Á¤ÀÌ´Ù. ADC´Â ÀÎü¿¡¼ ÁúȯÀ» À¯¹ßÇÏ´Â Ç׿øÀ» ¼±ÅÃÀûÀ¸·Î °ø°ÝÇÏ´Â Ç×ü¿Í Ä¡·á È¿°ú¸¦ Áö´Ñ ¾à¹°À» °áÇÕÇÏ´Â ±â¼úÀÌ´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ·¹°íÄÍ, ´ÙÄÉ´Ù ÀÚȸ»ç¿¡ 4500¾ï ±Ô¸ð ±â¼úÀÌÀü URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö